Triamcinolone acetonide-d<sub>7</sub>

Triamcinolone acetonide-d7

CAT N°: 25236
Price:

From 182.00 154.70

Triamcinolone acetonide-d7 is intended for use as an internal standard for the quantification of triamcinolone acetonide (Item No. 18026) by GC- or LC-MS. Triamcinolone acetonide is a synthetic corticosteroid.{43074} It decreases cytokine levels, the firing rate of sensory neurons, and mechanical hypersensitivity in a rat spinal nerve ligation model when used at a dose of 1.5 mg/kg prior to and following surgery for three days. Triamcinolone acetonide also decreases outflow facility in a mouse model of steroid-induced glaucoma when 20 µl of a 40 mg/ml suspension is administered subconjunctivally.{43075} Formulations containing triamcinolone acetonide are used in the treatment of diabetic macular edema.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-6b-fluoro-7-hydroxy-8b-(2-hydroxyacetyl-2-d)-6a,8a-dimethyl-10,10-bis(methyl-d3)-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2′,1′:4,5]indeno[1,2-d][1,3]dioxol-4-one
  • Correlated keywords
    • 352431-33-5 deuterated deuterium internal quantifies quantify quantification GC-MS GC/MS gas chromatography mass spectrometry LC-MS LC/MS liquid isotope NSC21916 NSC 21916 Adcortyl Aftach Aristicort Aristoderm Azmacort Berlicort Delphicort Extracort Ftorocort I-Vation Kenacort Kenalog Ledercort Lichtena MaQuaid Nasacort Omcilon A Paralen Pol’kortolon Queyanshusong Respicort Rheudenolone Rineton Solodelf TAC Tamceton Tramacin Tri-Nasal Triacet Triakort Triam Triamcort Triamhexal Triamonide 40 Trianopollon Tricinolon Triesence Trivaris Trymex Valon Vetalog Vetazine Volonimat
  • Product Overview:
    Triamcinolone acetonide-d7 is intended for use as an internal standard for the quantification of triamcinolone acetonide (Item No. 18026) by GC- or LC-MS. Triamcinolone acetonide is a synthetic corticosteroid.{43074} It decreases cytokine levels, the firing rate of sensory neurons, and mechanical hypersensitivity in a rat spinal nerve ligation model when used at a dose of 1.5 mg/kg prior to and following surgery for three days. Triamcinolone acetonide also decreases outflow facility in a mouse model of steroid-induced glaucoma when 20 µl of a 40 mg/ml suspension is administered subconjunctivally.{43075} Formulations containing triamcinolone acetonide are used in the treatment of diabetic macular edema.

We also advise you